Background: The imbalance in macrophage phenotype transition is a central mechanism driving chronic inflammation in diabetic kidney disease (DKD). Macrophages can polarize toward the M2 phenotype via ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. In The Lancet, Chantal ...

Background: In this study, we aim to evaluate the effects of hyaluronic acid and its derivatives on wound healing in diabetic foot ulcer. Methods: The electronic databases included PubMed, BIOSIS, ...

aDepartment of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, Uppsala, Sweden bUnit of Clinical Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, ...

Last week, a study involving more than nine million pregnancies reported that children whose mothers had gestational diabetes during pregnancy had a higher chance of developing attention ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...

Novo Nordisk A/S’s once-weekly diabetes drug was recommended for approval in the European Union, paving the way for patients to be able to access another option to control their condition. The ...

Along with measures like getting regular physical activity and managing stress, certain dietary changes can make a big difference in managing prediabetes and lowering the risk of type 2 diabetes. Pick ...

Please provide your email address to receive an email when new articles are posted on . Tirzepatide prevented cardiovascular events similarly to dulaglutide in patients with diabetes and heart disease ...

A daily pill previously shown to slow the progression of type 1 diabetes has now shown a loss of therapeutic benefit when stopped—affirming the promise of the treatment. In 2023, an Australian trial ...

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device. Benzinga reached out to DexCom for comments and is yet ...

VIENNA — Healthcare professionals should discuss the emotional side of diabetes at every visit, using open-ended questions framed around the burden or challenges of living with the condition, ...